Lv1
10 积分 2023-11-06 加入
Liver steatosis and fibrosis in China
7个月前
已完结
Liver steatosis and fibrosis in China
7个月前
已完结
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
10个月前
已完结
NASH drug treatment development: challenges and lessons
10个月前
已完结
Implementation of a liver health check in people with type 2 diabetes
10个月前
已完结
A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study
10个月前
已完结
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
11个月前
已完结
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
11个月前
已完结
Reply to: “Non-invasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cut-off values”
11个月前
已完结
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
1年前
已完结
皖公网安备34019202002308
